Prognostic Value of Structural and Functional Microvascular Dysfunction in Patients with Nonobstructive Coronary Artery Disease

Coronary microvascular dysfunction (CMD) is a paramount factor involved in the development of anginal syndromes. Among patients with angina and nonobstructive coronary artery disease with CMD, two patterns have been identified using minimal microvascular resistance: structural CMD, and functional CMD.

Valor pronóstico de disfunción microvascular estructural y funcional en pacientes con enfermedad coronaria no obstructiva

Structural CMD is characterized by decreased coronary flow reserve (CFR) in the presence of increased microvascular resistance. This subtype represents changes in the microvasculature such as arteriolar obliteration, which improves under conditions of maximal vasodilatation.

However, functional CMD is characterized by decreased CFR with normal or decreased microvascular resistance. This is related to increased myocardial oxygen demand or impaired coronary autoregulation. However, the prognostic relevance of these two CMD subtypes has not been evaluated.

The aim of this (multicenter, retrospective) ILIAS Registry was to evaluate the prognostic impact of structural vs. functional CMD in patients with nonobstructive coronary artery disease.

This study analyzed 1102 patients. Mean patient age was 63 years old, and 69% of subjects were male. The most analyzed artery was the anterior descending artery, followed by the circumflex artery. Patients were classified into four groups based on CFR (cutoff value <2.5), and two groups based on microvascular resistance: low and high (in terms of the microvascular resistance index [MRI] and the hyperemic microvascular resistance [HMR]).

Read also: Complicated Non-Stenotic Carotid Plaques: A Light in the Diagnosis of Cryptogenic Stroke?

Regarding the results, abnormal CFR values were associated with increased risk of MACE and treated vessel failure (TVF) at 5 years regardless of the values of microvascular resistance obtained. However, abnormal microvascular resistance values were not associated with increased MACE and TVF. Lastly, there were no differences between normal or abnormal microvascular resistance values in patients with normal CFR.

Conclusion

CMD, represented as a decrease in CFR, was associated with an increase in MACE and FVL at a 5-year follow-up. In contrast, microvascular resistance was not associated with adverse clinical events. In patients with CMD, there were no significant differences in MACE and TVF between structural CMD and functional CMD.

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member o the Editorial Board of SOLACI.org.

Original Title: Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry.

Reference: Coen K.M. Boerhout et al EuroIntervention 2022;18.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

CRT 2026 | NAVITOR IDE: Hemodynamic Outcomes and 5-Year Durability of an Intra-Annular Self-Expanding Transcatheter Aortic Valve

As TAVI expands into younger populations and patients with lower surgical risk, prosthesis durability has become a key aspect of long-term management. The NAVITOR...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...